Physician profile
David Shaw
NPI 1881626067
$739.92
in general payments reported to CMS, 2019-2025
13 companies · $190 in 2025
The $190 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $31.51 · 2022: $164 · 2024: $355 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $544.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $167.34 | 2024-2025 | Arista Ah Flexitip, Surgiphor |
| Zimmer Biomet Holdings, INC. | $145.70 | 2022 | |
| Medacta USA, INC. | $125.25 | 2024-2025 | Amistem, Reverse Shoulder |
| Paratek Pharmaceuticals, INC. | $123.79 | 2024 | Nuzyra |
| Azurity Pharmaceuticals, INC. | $38.03 | 2025 | Alvesco |
| Smith+Nephew, INC. | $24.06 | 2025 | Pico 14, "Acticoat 4"" X 4""", Pico 7 |
| Astrazeneca Pharmaceuticals LP | $19.57 | 2025 | Breztri |
| Boston Scientific Corporation | $18.30 | 2022 | |
| Medtronic, INC. | $18.10 | 2024 | Plasmablade(Tm) |
| Baudax Bio INC. | $17.56 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $14.97 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $13.95 | 2021 | |
| Endo USA, INC. | $13.30 | 2024 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.